关键信息
-
基因名
hmwC
- 应用
-
别名
Putative accessory processing protein
-
种属
Yersinia pestis
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A0H2W148
-
表达区间
1-584aa
-
分子量
73.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
HMWC (High Molecular Weight Complex) recombinant proteins have garnered significant attention in the field of biotechnology and pharmaceuticals due to their promising applications in various therapeutic and industrial processes. The research surrounding HMWC focuses on understanding the structure, function, and production of these proteins, which often exhibit unique biochemical properties that can be harnessed for improved efficacy in drug delivery, enzyme catalysis, and biomaterial development. The challenge in studying HMWC lies in their complex and often unstable nature, necessitating advanced techniques in protein engineering and expression systems to achieve optimal yields and activity. Recent advancements in genetic engineering, such as CRISPR/Cas9 and novel expression platforms, have enabled researchers to produce HMWC with enhanced stability and functionality. Additionally, investigations into the interactions of HMWC with other biomolecules have revealed their potential roles in cellular processes, opening new avenues for therapeutic intervention in diseases. As the biotechnology sector continues to evolve, the exploration of HMWC recombinant proteins holds the promise for innovative solutions in healthcare and environmental applications, making it a vibrant area of ongoing research.
